Skip to content

Effects of Cisatracurium on Sccinylcholine-induced Fasciculations

Effects of Pretreatment With Different Doses of Cisatracurium on Succinylcholine-induced Fasciculations

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02502032
Enrollment
87
Registered
2015-07-17
Start date
2015-07-31
Completion date
2015-10-31
Last updated
2015-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fasciculations

Brief summary

To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations.

Detailed description

Ninety patients scheduled for laparoscopic cholecystectomies were equally randomized into three groups to receive pretreatment of 0.005, 0.01, and 0.02 mg/kg cisatracurium, respectively. General anesthesia was induced 3.5 min later, train of four stimulation was monitored 4.5 min later, succinylcholine 1.5 mg/kg was injected 5 min later, and endotracheal intubation was implemented 6.5 min later. The side effects of cisatracurium, intensity of fasciculations, intubating conditions, time and extent to maximal depression of twitch and time for its recovery to 20% of control value, severity of myalgia at 24 h postoperatively, serum potassium before cisatracurium pretreatments, at intubating time, and 5 min after intubation were recorded.

Interventions

DRUGCisatracurium

Different groups received different pretreatments of cisatracurium.

Sponsors

Zhuan Zhang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* American Standards Association (ASA) physical status I or II patients scheduled for elective laparoscopic cholecystectomies with tracheal intubation requiring general anesthesia; * 20 - 65 years old; * Without acid-base imbalance and electrolyte disturbance; * With normal hepatic and renal function.

Exclusion criteria

* Patients with the contraindications associated with succinylcholine or cisatracurium; * Patients taking drugs known to alter the action of neuromuscular blockers; * Patients with a body mass index exceeding 30

Design outcomes

Primary

MeasureTime frame
Presence of fasciculationsAfter the injection of succinylcholine for 1.5 minutes

Secondary

MeasureTime frame
The time to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The extent to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
Side effects of the pretreatment of cisatracuriumFrom the time of 3 minutes after the pretreatment of cisatracurium for 0.5 minutes
The changes of serum potassiumAfter entering the operating theater till the anesthesia induction, at intubating, and 5 min after intubation
Myalgia at 24 hours postoperativelyAt 24 hours postoperatively
The grades of endotracheal intubationAt intubating time

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026